🟢 ADMA Biologics Inc is trading 80% up today after a sharp after-hours spike on no immediate news

ADMA Biologics Inc is trading 80% up at $15.18 after a sharp after-hours spike with no immediate public catalyst.

• The stock surged from its regular-session close of $8.42 despite a lack of confirmed earnings, FDA headlines, or company-specific news.
• The move may reflect reaction to undisclosed news, low-liquidity after-hours trading dynamics, or pending announcements.